Morin Charles M, Chen Si-Jing, Lemieux Kathleen, Ivers Hans, Cheung Janet M Y, Lamy Manon, Ritterband Lee
École de psychologie, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada; Centre de recherche CERVO/Brain Research Center, 2301 Av. D'Estimauville, Québec, Québec, G1E 1T2, Canada.
École de psychologie, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada; Centre de recherche CERVO/Brain Research Center, 2301 Av. D'Estimauville, Québec, Québec, G1E 1T2, Canada; Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China.
Sleep Med. 2025 Aug;132:106551. doi: 10.1016/j.sleep.2025.106551. Epub 2025 May 3.
To evaluate the effectiveness of a stepped-care intervention for insomnia in primary care.
In this non-randomized pragmatic clinical trial, patients from primary care clinics and with chronic insomnia disorder were allowed to choose between continuing their usual treatment (prescribed sleep medication) or receiving digital CBT-I (dCBT-I), either alone or in combination with medication. After the first treatment step, non-remitters were provided with the choice of receiving face-to-face CBT-I (FtFCBT-I), medication, or no additional treatment. The primary outcome was insomnia symptoms as measured by the Insomnia Severity Index.
Among 154 adults with insomnia, 73 were allocated to dCBT-I, 66 to combined treatment and 15 to medication alone based on their preference. When compared to medication alone, first-step treatment with dCBT-I or combined treatment both produced significantly larger effects on reducing insomnia severity (dCBT-I vs Med, difference in the mean changes = -3.3; Comb vs Med, -3.7), and led to higher percentages of responders (dCBT-I vs Med, 54.8 % vs 16.0 %, OR = 6.38; Comb vs Med, 53.6 % vs 16.0 %, OR = 6.07) and remitters (dCBT-I vs Med, 65.8 % vs 9.4 %, OR = 18.61; Comb vs Med, 67.5 % vs 9.4 %, OR = 20.13). Adding FtFCBT-I as second-step treatment offered an added value for non-remitters after the first-step treatment. Improvements achieved at post-treatment were sustained through the 6-month follow-up for most of the treatment sequences.
These findings demonstrated the feasibility and efficiency of implementing digital and in-person CBT-I within a stepped-care model in primary care practice.
ClinicalTrials.gov Identifier: NCT03633305.
评估初级保健中针对失眠的逐步护理干预措施的有效性。
在这项非随机实用临床试验中,来自初级保健诊所且患有慢性失眠症的患者可以选择继续其常规治疗(处方睡眠药物),或者接受数字认知行为疗法治疗失眠(dCBT-I),可单独使用或与药物联合使用。在第一个治疗步骤之后,未缓解的患者可以选择接受面对面认知行为疗法治疗失眠(FtFCBT-I)、药物治疗或不接受额外治疗。主要结局是通过失眠严重程度指数测量的失眠症状。
在154名患有失眠的成年人中,根据他们的偏好,73人被分配到dCBT-I组,66人被分配到联合治疗组,15人被分配到单独药物治疗组。与单独药物治疗相比,dCBT-I或联合治疗作为第一步治疗在降低失眠严重程度方面均产生了显著更大的效果(dCBT-I与药物治疗相比,平均变化差异=-3.3;联合治疗与药物治疗相比,-3.7),并导致更高比例的有反应者(dCBT-I与药物治疗相比,54.8%对16.0%,OR=6.38;联合治疗与药物治疗相比,53.6%对16.0%,OR=6.07)和缓解者(dCBT-I与药物治疗相比,65.8%对9.4%,OR=18.61;联合治疗与药物治疗相比,67.5%对9.4%,OR=20.13)。在第一步治疗后,为未缓解者添加FtFCBT-I作为第二步治疗提供了附加价值。对于大多数治疗序列,治疗后取得的改善在6个月的随访中得以维持。
这些发现证明了在初级保健实践的逐步护理模式中实施数字和面对面认知行为疗法治疗失眠的可行性和有效性。
ClinicalTrials.gov标识符:NCT03633305。